Total Return chart Regeneron Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-14 EDT			5-day change	1st Jan Change
803.48 ^USD	-0.31%		+2.44%	+4.10%

08-14	Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating	MT
07-31	Regeneron Pharmaceuticals' Robust Q2 Sales Amid Limited Spend Increases to Help Ramp H2 Margins, RBC Says	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.